Medical device manufacturers are optimistic the Trump administration will change anti-fraud policies to allow greater company participation in formal arrangements that coordinate care for patients.
Industry representatives and attorneys told Bloomberg Law they see an opportunity in the Department of Health and Human Services’ recent request for information (RIN:0936-AA10) for public comments, asking how the HHS can foster care coordination by modifying or adding safe harbors to the anti-kickback statute, such as making prices for devices contingent on whether patients improve.
Industry group AdvaMed sees the anti-kickback statute as the “top deterrent to more companies getting engaged in value-based arrangements,” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.